Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Unpack the common reasons budgeting is hard and learn approachable methods to develop healthier financial habits.
24,094 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A $10,000 SPY investment made the night of the 2024 election would be worth about $12,600 today, counting dividends. ...
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
AI-driven improvements are speeding mortgage processing, yet governance gaps loom. This piece examines the drive, ris...
SpaceX stock has surged past the $170 mark, shaking up the investing landscape. This article breaks down what drives ...
Finance America expands its HomeSafe Second reverse mortgage to four new markets, broadening access to housing wealth...
Tom Zschach, who led SWIFT's digital asset strategy for six years, publicly dismissed XRP partnership rumors on July ...
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
Lucid stock bounces back after a dramatic drop fueled by rumors. This guide explains what drove the move, what it mea...
A single insider move often sparks headlines, but context matters. This article digs into what this credo insider's s...
June inflation slowed, but the path for interest rates is far from clear. This piece unpacks these four words, explai...
A broad rally in nuclear stocks helped Constellation Energy ride the wave. This piece breaks down the catalysts, what...